Introduction and Background Information --;Basic Pharmacologic Properties: Peripheral Effects on Neurotransmission --;Basic Pharmacologic Properties: Central Effects --;Effects of Co-Dergocrine on the Cardiovascular System --;Effects of Co-Dergocrine on Other Organs and Cells --;The Clinical Pharmacology of Co-Dergocrine in Age-Related Cerebral Insufficiency --;Co-Dergocrine in Various Cardiovascular and Cerebral Indications --;Biopharmaceutical Aspects --;Toxicologic Considerations --;References.
SUMMARY OR ABSTRACT
Text of Note
A booklet published in 1979 presented the in- formation on one of these compounds, namely co-dergocrine (Hydergine@), as extracted from the Handbook and updated to take the latest developments into account [42].